Nektar Therapeutics
NKTR
#4678
Rank
A$3.34 B
Marketcap
A$97.85
Share price
-3.30%
Change (1 day)
120.10%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -A$0.23 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$55.63 Million. In 2025 the company made an earning of -A$0.22 Billion a decrease over its 2024 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.23 Billion4.61%
2025 -A$0.22 Billion30.44%
2024 -A$0.17 Billion-56.85%
2023 -A$0.39 Billion-24.31%
2022 -A$0.51 Billion-30.25%
2021 -A$0.74 Billion17.87%
2020 -A$0.62 Billion0.88%
2019 -A$0.62 Billion-164.46%
2018 A$0.95 B-810.61%
2017 -A$0.14 Billion-37.06%
2016 -A$0.22 Billion89.22%
2015 -A$0.12 Billion48.22%
2014 -A$75.94 Million-65.93%
2013 -A$0.23 Billion-6.81%
2012 -A$0.24 Billion28.95%
2011 -A$0.19 Billion258.8%
2010 -A$51.71 Million-63.94%
2009 -A$0.15 Billion-392.45%
2008 A$49.03 M-211.74%
2007 -A$43.89 Million-79.57%
2006 -A$0.22 Billion-16.9%
2005 -A$0.26 Billion81.53%
2004 -A$0.15 Billion54.19%
2003 -A$92.35 Million-33.87%
2002 -A$0.14 Billion-9.6%
2001 -A$0.16 Billion73.39%
2000 -A$89.08 Million108.9%
1999 -A$42.65 Million39.48%
1998 -A$30.58 Million60.02%
1997 -A$19.11 Million18.05%
1996 -A$16.19 Million31.82%
1995 -A$12.28 Million57.14%
1994 -A$7.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.24 B-17,168.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.77 B-7,058.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.67 B-6,070.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.71 Billion 233.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.34 B-8,740.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.45 B-9,734.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$7.38 M-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.33 B-255.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland